The induction of breast milk pertussis specific antibodies following gestational tetanus-diphtheria-acellular pertussis vaccination

Vaccine

Volumn 32, Issue 43, 2014, Pages 5632-5637

  Abu Raya, Bahaa ^a,b   Srugo, Isaac ^a,b   Kessel, Aharon ^a,b   Peterman, Michael ^a,b   Bader, David ^a,b   Peri, Regina ^a,b   Ashtamker, Nathanealla ^a   Gonen, Ron ^a,b   Bamberger, Ellen ^a,b  

^a BNAI ZION MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Breast milk; Pertussis; Secretory IgA; Tetanus diphtheria acellular pertussis; Vaccination

Indexed keywords

ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS VACCINE; FILAMENTOUS HEMAGGLUTININ; HEMAGGLUTININ; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLUENZA VACCINE; PERTACTIN; PERTUSSIS TOXIN; PROTEIN; STEROID; UNCLASSIFIED DRUG; BACTERIUM ANTIBODY; SECRETORY IMMUNOGLOBULIN;

ADULT; ARTICLE; BORDETELLA PERTUSSIS; BREAST MILK; CLINICAL ARTICLE; COLOSTRUM; CONTROLLED STUDY; DILUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEOMETRIC MEA CONCENTRATION; GEOMETRY; GESTATIONAL AGE; HUMAN; MEASUREMENT; PASSIVE IMMUNIZATION; PERTUSSIS; PREGNANT WOMAN; TREATMENT DURATION; IMMUNOLOGY; MIDDLE AGED; WHOOPING COUGH; YOUNG ADULT;

ADULT; ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; COLOSTRUM; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; MIDDLE AGED; MILK, HUMAN; WHOOPING COUGH; YOUNG ADULT;

EID: 84908447292     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.08.006     Document Type: Article

References (37)

1. Chiappini E., Stival A., Galli L., de Martino M. Pertussis re-emergence in the post-vaccination era. BMC Infect Dis 2013, 13:151. 10.1186/1471-2334-13-151.
2. Winter K., Harriman K., Zipprich J., Schechter R., Talarico J., Watt J., et al. California pertussis epidemic, 2010. J Pediatr 2012, 1:1091-1096.
3. Cherry J.D. Epidemic pertussis in 2012 - the resurgence of a vaccine-preventable disease. N Engl J Med 2012, 367:785-787.
4. Centers for Disease Control and Prevention (CDC) Pertussis epidemic - Washington. Morb Mortal Wkly Rep 2012, 61:517-522.
5. Centers for Disease Control and Prevention website, [accessed 07.04.14]. http://www.cdc.gov/pertussis/surv-reporting.html.
6. Amirthalingam G. Strategies to control pertussis in infants. Arch Dis Child 2013, 98(7):552-555. 10.1136/archdischild-2012-302968.
7. Stein-Zamir C., Shoob H., Abramson N., Zentner G. The impact of additional pertussis vaccine doses on disease incidence in children and infants. Vaccine 2010, 29(2):207-211. 10.1016/j.vaccine.2010.10.058.
8. Centers for Disease Control and Prevention (CDC) Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months. Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 2011, 60:1424-1426.
9. The center for disease control and prevention. Pertussis (Whooping Cough) - What You Need To Know. [accessed 07.04.14]. http://www.cdc.gov/Features/Pertussis/.
10. Liu B., Newburg D.S. Human milk glycoproteins protect infants against human pathogens. Breastfeed Med 2013, 8(4):354-362. 10.1089/bfm.2013.0016.
11. Halperin B.A., Morris A., Mackinnon-Cameron D., Mutch J., Langley J.M., McNeil S.A., et al. Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women. Clin Infect Dis 2011, 53(9):885-892. 10.1093/cid/cir538.
12. Maertens K., De Schutter S., Braeckman T., Baerts L., Van Damme P., De Meester I., et al. Breastfeeding after maternal immunisation during pregnancy: providing immunological protection to the newborn: a review. Vaccine 2014, 32(16):1786-1792. 10.1016/j.vaccine.2014.01.083.
13. Lichty J.A., Slavin B., Bradford W.L. An attempt to increase resistance to pertussis sin newborn infants by immunizing their mothers during pregnancy. J Clin Investig 1938, 17:613-621.
14. De Schutter S., Leuridan E., Maertens K., Baerts L., Van Damme P., De Meester I. Quantification of Bordetella pertussis toxin antibodies in breast milk: optimization of sample preparation of evaluation of commercial ELISA. Presented at the 10th international symposium on Bordetella 2013.
15. Levy O., Wynn J.L. A prime time for trained immunity: innate immune memory in newborns and infants. Neonatology 2014, 105:136-141. 10.1159/000356035.
16. Strunk T., Currie A., Richmond P., Simmer K., Burgner D. Innate immunity in human newborn infants: prematurity means more than immaturity. J Matern Fetal Neonatal Med 2011, 24(1):25-31. 10.3109/14767058.2010.482605.
17. Belderbos M.E., van Bleek G.M., Levy O., Blanken M.O., Houben M.L., Schuijff L., et al. Skewed pattern of Toll-like receptor 4-mediated cytokine production in human neonatal blood: low LPS-induced IL-12p70 and high IL-10 persist throughout the first month of life. Clin Immunol 2009, 133(2):228-237. 10.1016/j.clim.2009.07.003.
18. Munoz F., Englund J. Infant pertussis: is cocooning the answer?. Clin Infect Dis 2011, 53:893-896. 10.1093/cid/cir542.
19. de Greeff S.C., Mooi F.R., Westerhof A., Verbakel J.M., Peeters M.F., Heuvelman C.J., et al. Pertussis disease burden in the household: how to protect young infants. Clin Infect Dis 2010, 50(10):1339-1345. 10.1086/652281.
20. Leurridan E., Hens N., Peeters N., De Witte L., Van der Meeren O., Van Damme P. Effect of a prepregnancy pertussis booster dose on maternal antibody titers in young infants. Pediatr Infect Dis J 2011, 30(7):608-610. 101097/INF.0b013e3182093814.
21. Gall S.A., Myers J., Pichichero M. Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels. Am J Obstet Gynecol 2011, 204(4):334.e1-334.e5. 1016/j.ajog.2010.11.024.334:e1-e5.
22. Healy C.M., Rench M.A., Baker C.J. Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants. Clin Infect Dis 2013, 56(4):539-544. 10.1093/cid/cis923.
23. Hardy-Fairbanks A.J., Pan S.J., Decker M.D., Johnson D.R., Greenberg D.P., Kirkland K.B., et al. Immune responses in infants whose mothers received Tdap vaccine during pregnancy. Pediatr Infect Dis J 2013, 32(11):1257-1260. 10.1097/INF.0b013e3182a09b6a.
24. Hewlett E.L., Burns D.L., Cotter P.A., Harvill E.T., Merkel T.J., Quinn C.P., et al. Pertussis pathogenesis - what we know and what we don't know. J Infect Dis 2014, 209(7):982-985. 10.1093/infdis/jit639.
25. Melvin J.A., Scheller E.V., Miller J.F., Cotter P.A. Bordetella pertussis pathogenesis: current and future challenges. Nat Rev Microbiol 2014, 12(4):274-288. 10.1038/nrmicro3235.
26. de Gouw D., Diavatopoulos D.A., Bootsma H.J., Peter W.M., Hermans P.W.M., Mooi F.R. Pertussis: a matter of immune modulation. FEMS Microbiol Rev 2011, 35(3):441-474. 10.1111/j.1574-6976.2010.00257.x.
27. Oguchi M., Syouji H., Shinohara K., Shimizu T., Yamashiro Y. Physiologically active substances and digestive tract function in human milk. Perinat Med 2004, 34:1345-1349.
28. Munoz F.M., Englund J.A., Cheesman C.C., Maccato M.L., Pinell P.M., Nahm M.H., et al. Maternal immunization with pneumococcal polysaccharide vaccine in the third trimester of gestation. Vaccine 2001, 20:826-837.
29. Groer M., Davis M., Casey K., Short B., Smith K., Groer S. Neuroendocrine and immune relationships in postpartum fatigue. Am J Matern Child Nurs 2005, 30:133-138.
30. Groer M., Mitzi D., Kathryn S. Associations between human milk SIgA and maternal immune, infectious, endocrine, and stress variables. J Hum Lact 2004, 20(2):153-158.
31. Butte N.F., Garza C., Johnson C.A., Smith E.O., Nichols B.L. Longitudinal changes in milk composition of mothers delivering preterm and term infants. Early Hum Dev 1984, 9(2):153-162.
32. Shahid N.S., Steinhoff M.C., Roy E., Begum T., Thompson C.M., Siber G.R. Placental and breast transfer of antibodies after maternal immunization with polysaccharide meningococcal vaccine: a randomized, controlled evaluation. Vaccine 2002, 20:2404-2409.
33. Schlaudecker E.P., Steinhoff M.C., Omer S.B., McNeal M.M., Roy E., Arifeen S.E., et al. IgA and neutralizing antibodies to influenza a virus in human milk: a randomized trial of antenatal influenza immunization. PLOS ONE 2013, 8:e70867.
34. Shahid N.S., Steinhoff M.C., Hoque S.S., Begum T., Thompson C., Siber G.R. Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine. Lancet 1995, 346:1252-1257.
35. Obaro S.K., Deubzer H.E., Newman V.O., Adegbola R.A., Greenwood B.M., Hender-son D.C. Serotype-specific pneumococcal antibodies in breast milk of Gambian women immunized with a pneumococcal polysaccharide vaccine during pregnancy. Pediatr Infect Dis J 2004, 23:1023-1029.
36. Asensi M.T., Martínez-Costa C., Buesa J. Anti-rotavirus antibodies in human milk: quantification and neutralizing activity. J Pediatr Gastroenterol Nutr 2006, 42(5):560-567.
37. Tuaillon E., Valea D., Becquart P., Al Tabaa Y., Meda N., Bollore K., et al. Human milk-derived B cells: a highly activated switched memory cell population primed to secrete antibodies. J Immunol 2009, 182(11):7155-7162.